The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > Shire BioChem Inc.

Shire BioChem Inc.
 PROFILE
Shire-Biochem Pharma (formerly BioChem Pharma, now a subsidiary of the UK's Shire Pharmaceuticals) runs with the big boys. Through an alliance with UK pharmaceutical giant Glaxo Wellcome (now GlaxoSmithKline), the company developed 3TC (marketed outside of Canada as Epivir), the world's bestselling HIV treatment, which is used with Glaxo's Retrovir for the treatment of AIDS; and Zeffix, which is sold in over 30 countries for the treatment of chronic hepatitis B. Shire-BioChem also makes vaccines for the flu, meningitis, and pneumonia, and is developing treatments for bladder cancer.

 COMPETITION
Abbott Laboratories (ABT)
Biogen, Inc. (BGEN)
Chiron Corporation (CHIR)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 216.80
1-Yr. Sales Growth: 13.7%
Employees: 500
Revenue per employee: $433,600.00

 KEY PEOPLE
• Joseph Rus
    CEO

 CONTACT INFO
275 Armand-Frappier Blvd.
Laval Quebec H7V 4A7, Canada
Phone: 1-450-978-7800
Fax: 1-450-978-7755
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001